5 updated risk factors for heart disease, diabetes detection
By
Alicia Lasek
Jul 31, 2019
To detect diabetes and heart disease early on, clinicians should focus on five key risk factors, according to a guideline released this week.
After disaster, mortality risk spikes 40% for seniors with diabetes
By
Alicia Lasek
Sep 23, 2019
In counties that were directly impacted by hurricanes Katrina and Rita, older adults with diabetes took a big hit to their health.
Diabetes dangers in LTC can be reduced by better self-management education
By
Alicia Lasek
Aug 05, 2019
Dangerous hypoglycemic events in long-term care settings can be reduced with diabetes self-management education and support.
Chronic loneliness predicts type 2 diabetes onset in older adults, study finds
By
Alicia Lasek
Sep 16, 2020
Isolation or living alone did not predispose study participants to diabetes, but loneliness due to poor-quality relationships did, investigators say.
Diabetes is the No. 1 co-morbid condition linked to nursing home pressure ulcers, analysis finds
By
Tim Mullaney
Mar 03, 2014
Diabetes is the co-morbid condition most strongly associated with the development of pressure ulcers in nursing home residents, according to a new analysis of existing research.
FDA issues recall notice on Nova strips
By
Elizabeth Newman
Sep 01, 2013
Providers should monitor residents with diabetes to see if they are using recalled blood glucose test trips, the U.S. Food and Drug Administration has advised.
FDA approves first biosimilar insulin product
Jul 29, 2021
Semglee (insulin glargine-yfgn) is biosimilar to and interchangeable with Lantus (insulin glargine), provides cost-effective option
Care improvements reduce amputations
By
John O'Connor
Aug 01, 2013
Advances in diabetic foot ulcer treatments are helping reduce lower-extremity amputations, a new study finds. Researchers at the University of Iowa Department of Orthopaedics and Rehabilitation studied...
Drug that targets Alzheimer’s inflammation approved for trial by FDA
By
Alicia Lasek
Feb 09, 2021
An experimental drug meant to treat the “type 3 diabetes” that some scientists believe triggers Alzheimer’s has been approved for a late-stage clinical trial.
Drug company to pay $3 billion to settle criminal charges
Jul 02, 2012
In what is the biggest healthcare fraud settlement in U.S. history, drugmaker GlaxoSmithKline will pay $3 billion and plead guilty to illegally promoting prescription drugs.